Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Altered expression of metabolic proteins and adipokines in patients with amyotrophic lateral sclerosis

7 Jul 2015

Abstract excerpt

Amyotrophic lateral sclerosis (ALS) is an adult-onset neurodegenerative disease characterized by the loss of upper cortical and lower motor neurons. ALS causes death within 2-5years of diagnosis. Diet and body mass index influence the clinical course of disease, however there is limited information about the expression of metabolic proteins and fat-derived cytokines (adipokines) in ALS. In healthy controls and...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Amyotrophic Lateral Sclerosis Research
Share to Genetic Neurodegenerative Diseases
Share to Neurogenetic and Muscular Disorders Research

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 26198021
DOI: 10.1016/j.jns.2015.06.053

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Altered expression of metabolic proteins and adipokines in patients with amyotrophic lateral sclerosisPMID 26198021Read ↗

Serum C-Peptide, Visfatin, Resistin, and Ghrelin are Altered in Sporadic and GRN-Associated Frontotemporal Lobar Degeneration.Semantic proximity Read ↗

Differential gene expression in patients with amyotrophic lateral sclerosisSemantic proximity Read ↗

Biomarkers for amyotrophic lateral sclerosis.Semantic proximity Read ↗

Hypothesis-free evaluation of circulating metabolome provides cell-specific insights regarding the role of energy substrate availability in amyotrophic lateral sclerosisSemantic proximity Read ↗

A plasma proteomics-based candidate biomarker panel predictive of amyotrophic lateral sclerosisSemantic proximity Read ↗

Proteomic analysis of cerebrospinal fluid in amyotrophic lateral sclerosisSemantic proximity Read ↗

Identification of Regulatory Factors and Prognostic Markers in Amyotrophic Lateral SclerosisSemantic proximity Read ↗

Unveiling amyotrophic lateral sclerosis complexity: insights from proteomics, metabolomics, and microbiomicsSemantic proximity Read ↗

Leptin haploinsufficiency exerts sex-dependent partial protection in SOD1G93A mice by reducing inflammatory pathways in the adipose tissueSemantic proximity Read ↗

Plasma profiling reveals three proteins associated to amyotrophic lateral sclerosisSemantic proximity Read ↗

Progressive muscle metabolic reprogramming in asymptomatic ALS gene mutation carriersSemantic proximity Read ↗

Abnormal energy metabolism in ALS: a key player?Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.